Virtu KCG Holdings’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q2
Sell
-24,480
Closed -$111K 3030
2017
Q1
$111K Buy
24,480
+1,764
+8% +$8K ﹤0.01% 2633
2016
Q4
$57K Buy
22,716
+9,368
+70% +$23.5K ﹤0.01% 3040
2016
Q3
$42K Buy
+13,348
New +$42K ﹤0.01% 2805
2016
Q1
Sell
-15,057
Closed -$51K 2924
2015
Q4
$51K Buy
+15,057
New +$51K ﹤0.01% 2618